Flexogenix
Flexogenix is a private U.S. healthcare services company founded in 2013 and headquartered in Cary, NC, providing minimally invasive, non-surgical treatments for chronic knee pain, primarily to patients with knee osteoarthritis seeking alternatives to surgery.
- Company typePrivate
- Founded2013
- HeadquartersCary, United States
- Headcount101–250
- GTM typeB2C
- OfferingServices
What Flexogenix does
Flexogenix is a private, for-profit U.S. healthcare services company headquartered in Cary, North Carolina, founded in 2013. According to the firm's own description, it specializes in providing minimally invasive, cost-effective, non-surgical solutions — specifically in the orthopedic pain management category, with a focus on knee osteoarthritis and related joint conditions, as suggested by the operation of the arthritiskneepain.com consumer web property.
The company's core offering is a clinical, non-surgical procedure protocol for patients suffering from chronic knee pain, positioned as an alternative to invasive surgical interventions such as knee replacement. The underlying technology is centered on proprietary injection-based or regenerative treatment protocols delivered in an outpatient clinic setting; no proprietary software, AI models, or digital platforms are disclosed. The company appears to rely on a consumer-facing marketing channel in addition to physician referrals to drive patient acquisition.
Operationally, Flexogenix has scaled to 101-250 employees, consistent with a multi-site clinic model across multiple U.S. geographies. The revenue model is direct-to-consumer healthcare services, with payment likely coming from a mix of patient out-of-pocket spend and third-party reimbursement. No public pricing, payer mix, funding, or financial disclosures are available in the current data set.
Flexogenix firmographics
Firmographics- Name
- Flexogenix
- Website
- https://flexogenix.com
- Company type
- Private
- Founded year
- 2013
- Headcount range
- 101–250 employees
- Short description
- Flexogenix is a private U.S. healthcare services company founded in 2013 and headquartered in Cary, NC, providing minimally invasive, non-surgical treatments for chronic knee pain, primarily to patients with knee osteoarthritis seeking alternatives to surgery.
- Ownership category
- akta.pro rank
Flexogenix industry classification
Industry- Product category
- Orthopedic Pain Management Services
- NAICS
- Other Ambulatory Health Care Services (6219), Freestanding Ambulatory Surgical and Emergency Centers (621493)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Hip & Knee Reconstruction (Arthroplasty) (HLAKALAH)
- akta.pro secondary industries
- General Orthopedics (HLAKALAA), Pain Management (Spine & Musculoskeletal) (HLAKALAM)
Keywords
Where Flexogenix is headquartered
LocationHeadquarters
- HQ city
- Cary
- HQ country
- United States
- HQ region
- North America
Markets served
Flexogenix business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D
Flexogenix product offering
Product offeringCore offering
Flexogenix operates outpatient clinics that deliver minimally invasive, non-surgical treatments for chronic knee pain caused by osteoarthritis and related joint conditions. Its services include image-guided injections and other regenerative-style therapies aimed at relieving pain and restoring mobility without the downtime of knee-replacement surgery.
Differentiator
Problem solved
Functional benefit
Products and services
- Non-Surgical Knee Pain Treatment Minimally invasive, non-surgical knee pain therapy delivered at Flexogenix clinics for adult patients with osteoarthritis or chronic knee joint pain who want to avoid knee-replacement surgery.
Companies that use Flexogenix
Customer profileIdeal customer profiles1 record
Flexogenix technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Flexogenix partnerships and signals
Strategic signalRecent moves3 records
Expansion highlights3 records
Flexogenix competitors and assessment
Company assessmentEmerging players
- Athletico Physical Therapy: Large outpatient rehabilitation chain increasingly offering non-surgical conservative-care programs for knee osteoarthritis; adjacent competitor in the conservative orthopedic pathway.
- StemCell Institute (Panama): Stem-cell treatment provider for orthopedic and joint conditions including knee arthritis; competes for medical-tourism and cash-pay patients seeking regenerative alternatives to surgery.
Direct peers
- Regenexx: National network of clinics offering non-surgical orthopedic treatments including regenerative injections for knee and joint pain; competes directly with Flexogenix for patients seeking alternatives to joint replacement.
- Genicular Artery Embolization (GAE) providers (e.g., Vascular Institute of the Midwest): Interventional radiology practices offering genicular artery embolization as a minimally invasive knee arthritis treatment; overlaps with Flexogenix's core procedural modality.
- Joint Relief Institute: Outpatient practice specializing in non-surgical knee pain relief through viscosupplementation and related injections; direct competitor serving similar demographic with comparable treatment philosophy.
- Arthritis Knee Pain Centers: Multi-site clinic brand offering non-surgical, image-guided treatments for knee osteoarthritis; shares Flexogenix's direct-to-patient knee-pain positioning and consumer-marketing approach.
Broad incumbents
- Rothman Orthopaedic Institute: Large multi-specialty orthopedic group adding non-surgical and regenerative options across the Mid-Atlantic and Florida; competes for the same knee-pain patient pool with broader service portfolio.
- Hospital for Special Surgery (HSS): Premier orthopedic hospital that has expanded non-surgical and biologic offerings for knee arthritis; represents the established incumbent whose surgical franchise Flexogenix is positioned against.
- Cleveland Clinic Orthopaedic & Rheumatologic Institute: Major health system offering comprehensive orthopedic care including non-surgical knee pain management; represents large-system competition with payer integration and brand scale advantages.
Regional players
- NYC Stem Cell / Regenexx NY: Regional regenerative-medicine clinic in the Northeast offering non-surgical orthopedic treatments including knee injections; comparable service mix but geographically concentrated.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat3 records
Key risks5 records
Key highlights5 records
Customer concentration
Flexogenix social profiles
Digital presenceFlexogenix financial estimates
Financial estimateRevenue estimate
Valuation estimate
Flexogenix leadership team
Management profileNumber of profiles
Flexogenix funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Flexogenix M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Flexogenix
What does Flexogenix do?
Flexogenix operates outpatient clinics that deliver minimally invasive, non-surgical treatments for chronic knee pain caused by osteoarthritis and related joint conditions. Its services include image-guided injections and other regenerative-style therapies aimed at relieving pain and restoring mobility without the downtime of knee-replacement surgery.
When was Flexogenix founded?
Flexogenix was founded in 2013. It employs 101 to 250 people.
Where is Flexogenix based?
Flexogenix is headquartered in Cary, United States, in the North America region.
Who are Flexogenix's main competitors?
Emerging players on record are Athletico Physical Therapy and StemCell Institute (Panama). Direct peers are Regenexx, Genicular Artery Embolization (GAE) providers (e.g., Vascular Institute of the Midwest), Joint Relief Institute and Arthritis Knee Pain Centers. Broad incumbents are Rothman Orthopaedic Institute, Hospital for Special Surgery (HSS) and Cleveland Clinic Orthopaedic & Rheumatologic Institute. NYC Stem Cell / Regenexx NY is listed as a regional player.
Does Flexogenix have an API?
No public API is recorded for Flexogenix.
What industry is Flexogenix in?
Flexogenix's product category is Orthopedic Pain Management Services. Its primary akta.pro industry code is HLAKALAH, Hip & Knee Reconstruction (Arthroplasty), with a secondary code of HLAKALAA, General Orthopedics. Its NAICS code is 6219 and its SIC code is 8011.